Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
2
67%
Ph phase_4
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(1)
Other(2)

Detailed Status

unknown2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

terminated133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
unknownnot_applicable

Dose-staged Gamma Knife Radiosurgery Versus Microsurgical Resection

NCT04857905
terminatednot_applicable

Endocrine Outcome of Surgery for Pituitary Adenoma

NCT03515603
unknownphase_4

Evaluation of Resection Quality of Cerebral Metastases Using Fluorescence Guided Surgery: a Prospective Randomised Study

NCT04116801

Clinical Trials (3)

Showing 3 of 3 trials
NCT04857905Not Applicable

Dose-staged Gamma Knife Radiosurgery Versus Microsurgical Resection

Unknown
NCT03515603Not Applicable

Endocrine Outcome of Surgery for Pituitary Adenoma

Terminated
NCT04116801Phase 4

Evaluation of Resection Quality of Cerebral Metastases Using Fluorescence Guided Surgery: a Prospective Randomised Study

Unknown

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3